I'm happy to sit on my shares and wait for another liquidity event or a higher price based on earnings multiples. But I will not be selling to a board who have no regard for shareholders.
if this really is being compared to some of the biggest tech names out there (Atlassian, aferpay etc by Deloitte), there is no way Montu doesn't get listsed and then taken out by Big Pharma somewhere down the track. My view is that it wont be at a val of $1.15/sh!!
My own opinion. Do your own research. Said without prejudice.
